Kalle Sipilä1, Antti Tikkakoski1, Sanni Alanko1, Atte Haarala1, Jussi Hernesniemi2,3, Leo-Pekka Lyytikäinen2, Jari Viik3, Terho Lehtimäki3,4, Tuomo Nieminen5,6, Kjell Nikus2,3, Mika Kähönen1,3. 1. Department of Clinical Physiology and Nuclear Medicine, Tampere University Hospital, Tampere, Finland. 2. Heart Center, Tampere University Hospital, Tampere, Finland. 3. Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland. 4. Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland. 5. Department of Internal Medicine, University of Helsinki, Helsinki University Central Hospital, Helsinki, Finland. 6. South Karelia Central Hospital, Lappeenranta, Finland.
Abstract
Aims: We investigated the combination of low systolic blood pressure (SBP) response, low exercise capacity (EC) and slow heart rate recovery (HRR) during an exercise test in mortality prediction.Patients and methods: Our population consisted of 3456 patients from the Finnish Cardiovascular Study. A failure of SBP to increase >42 mmHg was defined as a low response. Low EC was defined as < 8 metabolic equivalents. 1-minute HRR ≤18 bpm from maximum was defined as slow HRR. Results: During a median follow up of 10.0 years, 537 participants died. Reduced SBP response, low EC and slow HRR were independent predictors of all-cause and CV mortality (p < .001 for all). Patients with reduced SBP response, low EC and slow HRR had a very high mortality rate of 42.1% during follow up compared to only 4.5% of the patients without any of these risk factors. The hazard ratios for all-cause mortality in patients with one, two or three of the studied risk factors were 3.2, 6.0, and 10.6, respectively (p < .001 for all). Conclusion: The combination of reduced SBP response, low exercise capacity, and reduced HRR in an exercise test is associated with very high mortality and can be used in risk stratification.Key messagesThe combination of low blood pressure response, low exercise capacity and slow heart rate recovery in an exercise test is able to identify a group of patients in a very high mortality risk.These parameters are easily derived from an exercise test.All parameters are commonly available in clinical practice.
Aims: We investigated the combination of low systolic blood pressure (SBP) response, low exercise capacity (EC) and slow heart rate recovery (HRR) during an exercise test in mortality prediction.Patients and methods: Our population consisted of 3456 patients from the Finnish Cardiovascular Study. A failure of SBP to increase >42 mmHg was defined as a low response. Low EC was defined as < 8 metabolic equivalents. 1-minute HRR ≤18 bpm from maximum was defined as slow HRR. Results: During a median follow up of 10.0 years, 537 participants died. Reduced SBP response, low EC and slow HRR were independent predictors of all-cause and CV mortality (p < .001 for all). Patients with reduced SBP response, low EC and slow HRR had a very high mortality rate of 42.1% during follow up compared to only 4.5% of the patients without any of these risk factors. The hazard ratios for all-cause mortality in patients with one, two or three of the studied risk factors were 3.2, 6.0, and 10.6, respectively (p < .001 for all). Conclusion: The combination of reduced SBP response, low exercise capacity, and reduced HRR in an exercise test is associated with very high mortality and can be used in risk stratification.Key messagesThe combination of low blood pressure response, low exercise capacity and slow heart rate recovery in an exercise test is able to identify a group of patients in a very high mortality risk.These parameters are easily derived from an exercise test.All parameters are commonly available in clinical practice.
Authors: K Shetler; R Marcus; V F Froelicher; S Vora; D Kalisetti; M Prakash; D Do; J Myers Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Pia Pajunen; Heli Koukkunen; Matti Ketonen; Tapani Jerkkola; Pirjo Immonen-Räihä; Päivi Kärjä-Koskenkari; Markku Mähönen; Matti Niemelä; Kari Kuulasmaa; Pertti Palomäki; Juha Mustonen; Aapo Lehtonen; Matti Arstila; Tapio Vuorenmaa; Seppo Lehto; Heikki Miettinen; Jorma Torppa; Jaakko Tuomilehto; Y Antero Kesäniemi; Kalevi Pyörälä; Veikko Salomaa Journal: Eur J Cardiovasc Prev Rehabil Date: 2005-04
Authors: Antti M Kiviniemi; Samuli Lepojärvi; Tuomas V Kenttä; M Juhani Junttila; Juha S Perkiömäki; Olli-Pekka Piira; Olavi Ukkola; Arto J Hautala; Mikko P Tulppo; Heikki V Huikuri Journal: Am J Cardiol Date: 2015-08-31 Impact factor: 2.778
Authors: Martha Gulati; Dilip K Pandey; Morton F Arnsdorf; Diane S Lauderdale; Ronald A Thisted; Roxanne H Wicklund; Arfan J Al-Hani; Henry R Black Journal: Circulation Date: 2003-09-15 Impact factor: 29.690
Authors: Inge I de Liefde; Sanne E Hoeks; Yvette R B M van Gestel; Jan Klein; Hence J M Verhagen; Ron T van Domburg; Don Poldermans Journal: Coron Artery Dis Date: 2008-12 Impact factor: 1.439
Authors: Tuomo Nieminen; Rami Lehtinen; Jari Viik; Terho Lehtimäki; Kari Niemelä; Kjell Nikus; Mari Niemi; Janne Kallio; Tiit Kööbi; Väinö Turjanmaa; Mika Kähönen Journal: BMC Cardiovasc Disord Date: 2006-03-03 Impact factor: 2.298